Document is current
Any future updates will be listed below
-
Authors
Brites, Carlos
Luz, Estela
Stelitano, Cristiani
Bahia, Fabianna
de Lacerda, Marcus Vinícius Guimarães
Ramalho, Aline
Cardoso, Sandra Wagner
Madruga, Valdez
Reuter, Tânia
Barbosa, Alexandre Naime
Sperhack, Rosa Dea
Bay, Monica Baumgardt
Newman, Tâmara
Morejon, Karen
Patelli, Maria
Leal, Fábio
Sprinz, Eduardo
Murray-Krezan, Cristina
Carmody, Mary
Anderson, Jess
Aragon, Alejandro
Chase, Benjamin
Zajdenverg, Roberto
Jones, Bryn
Dutra, Fatima
Page, Kimberly
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 15 September 2025
First Online: 8 October 2025
Declarations
:
: Ethical approval has been obtained from the IRBs at each participating site, and all participants will provide written informed consent prior to enrollment.
: Not aplicable.
: CB: Research grants: CNPq, GSK, Pfizer, Janssen. All but CNPq grants were awarded to Fundação Bahiana de Infectologia; Speaker and Advisory board (Gilead, GSK, MSD); SCW: Advisory Boar (ViiV); VM: Speaker (GSK, Gilead, Janssen); ANB: Speaker (Abbvie, Amgen-Bergamo, Astrazeneca, Boehringer Ingelheim, Celltrion, Dr. Reedys, Eurofarma, Gilead, GSK-ViiV, Janssen, Knigth Therapeutics, Moderna, MSD, Pfizer, Procter Gamble, Roche, Sanofi Pasteur, S. C. Johnson Johnson, Takeda, e Wyeth); KP: Has received research grants from the U.S. National Institutes of Health, and U.S. Centers for Disease Control and Prevention. All grants were awarded to the University of New Mexico. RZ: GSK employee; BJ: ViiV Healthcare employee.
